Canada markets closed

Generation Bio Co. (GBIO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
4.7800-0.1600 (-3.24%)
At close: 04:00PM EDT
4.7800 0.00 (0.00%)
After hours: 04:01PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close4.9400
Open5.0000
Bid4.6900 x 1100
Ask4.6900 x 1000
Day's Range4.6200 - 4.9400
52 Week Range3.9600 - 26.0700
Volume232,554
Avg. Volume313,352
Market Cap282.074M
Beta (5Y Monthly)1.95
PE Ratio (TTM)N/A
EPS (TTM)-2.2690
Earnings DateNov 08, 2022 - Nov 14, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est21.75
  • GlobeNewswire

    Generation Bio to Present at the 2022 Jefferies Cell and Genetic Medicine Summit

    CAMBRIDGE, Mass., Sept. 22, 2022 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced that the company will participate in a fireside chat at the 2022 Jefferies Cell & Genetic Medicine Summit on Thursday, September 29th at 10:30 a.m. ET in New York. A live webcast of the presentation will be available on the investor section of the company’s website at investors.generationbio.com.

  • GlobeNewswire

    Generation Bio Names Phillip Samayoa, Ph.D. Chief Strategy Officer

    CAMBRIDGE, Mass., Sept. 20, 2022 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced the promotion of Phillip Samayoa, Ph.D., to chief strategy officer. Dr. Samayoa has led strategy, corporate and portfolio development at Generation Bio since he joined the company in 2017, most recently serving as senior vice president. “Phillip has been instrumental in building a holistic strate

  • Simply Wall St.

    A number of insiders bought Generation Bio Co. (NASDAQ:GBIO) stock last year, which is great news for shareholders

    When a single insider purchases stock, it is typically not a major deal. However, when multiple insiders purchase...